A report was received on 20 jul 2022 from the health care provider of a 56 year old male patient with a medical history including end stage renal disease, who stated the patient experienced a suspected intolerance reaction during multiple home hemodialysis treatments requiring noninvasive medical intervention over the previous 2-3 weeks.Symptoms included decreased blood pressure (nos), stomach sickness, shortness of breath, and palpitations.The patient was transferred to in-center hemodialysis treatment for two weeks and blood tests showed increased levels of eosinophils and leukocytes.As of (b)(6) 2022 the patient has returned to home hemodialysis and treated successfully with no adverse reaction.
|